FDA authorizes use of new device to treat esophageal birth defect in babies

By Newsroom America Feeds at 12 May 12:51

The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm558241.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL